phosphorylcholine has been researched along with Adenocarcinoma Of Kidney in 5 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Excerpt | Relevance | Reference |
---|---|---|
"Perifosine is an oral alkylphospholipid which has recently been assessed clinically in patients with advanced renal cell carcinoma (RCC)." | 2.49 | Perifosine in renal cell carcinoma. ( Cho, DC; Srivastava, N, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holland, WS | 1 |
Tepper, CG | 1 |
Pietri, JE | 1 |
Chinn, DC | 1 |
Gandara, DR | 1 |
Mack, PC | 1 |
Lara, PN | 1 |
Cho, DC | 2 |
Hutson, TE | 1 |
Samlowski, W | 1 |
Sportelli, P | 1 |
Somer, B | 1 |
Richards, P | 1 |
Sosman, JA | 1 |
Puzanov, I | 1 |
Michaelson, MD | 1 |
Flaherty, KT | 1 |
Figlin, RA | 1 |
Vogelzang, NJ | 1 |
Srivastava, N | 1 |
Settelen, N | 1 |
Roch, O | 1 |
Bock, D | 1 |
Rooke, R | 1 |
Braun, S | 1 |
Meyer, O | 1 |
Barna, BP | 1 |
James, K | 1 |
Deodhar, SD | 1 |
1 review available for phosphorylcholine and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Perifosine in renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Kidney Neoplasms; Molec | 2013 |
1 trial available for phosphorylcholine and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Disease Progression; Female; Follow-Up Studies; Huma | 2012 |
3 other studies available for phosphorylcholine and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resist | 2012 |
Controlled plasmid gene transfer to murine renal carcinoma by hexadecylphosphocholine.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Delayed-Action Preparations; Dose-Response Relatio | 2004 |
Activation of human monocyte tumoricidal activity by C-reactive protein.
Topics: Astrocytes; Astrocytoma; C-Reactive Protein; Carcinoma, Renal Cell; Cell Line; Cytotoxicity Tests, I | 1987 |